These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18971141)

  • 1. Occult fallopian tube cancer in a patient with BRCA1 breast cancer.
    Brown JV; Epstein HD; Mattison JN; Micha JP; Rettenmaier MA; Goldstein BH
    J Minim Invasive Gynecol; 2008; 15(6):749-51. PubMed ID: 18971141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.
    Paley PJ; Swisher EM; Garcia RL; Agoff SN; Greer BE; Peters KL; Goff BA
    Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.
    Kuji S; Kondo H; Ohara T; Deura I; Tozawa-Ono A; Migita O; Kawamoto H; Tsugawa K; Chosokabe M; Koike J; Maeda I; Suzuki N
    Jpn J Clin Oncol; 2021 Mar; 51(3):492-497. PubMed ID: 33377156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoma of the fallopian tube after prophylactic laparoscopic ovariectomy in a patient with a BRCAI mutation].
    Dijkhuizen FP; Huisman A; Boonstra H; Aalders AL
    Ned Tijdschr Geneeskd; 2003 May; 147(18):877-9. PubMed ID: 12756880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy.
    McEwen AR; McConnell DT; Kenwright DN; Gaskell DJ; Cherry A; Kidd AM
    Gynecol Oncol; 2004 Mar; 92(3):992-4. PubMed ID: 14984974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
    Callahan MJ; Crum CP; Medeiros F; Kindelberger DW; Elvin JA; Garber JE; Feltmate CM; Berkowitz RS; Muto MG
    J Clin Oncol; 2007 Sep; 25(25):3985-90. PubMed ID: 17761984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT; Crawford B; Chen LM; Powell CB; Zaloudek CJ
    Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
    Kauff ND; Barakat RR
    J Clin Oncol; 2007 Jul; 25(20):2921-7. PubMed ID: 17617523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
    Rabban JT; Krasik E; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Dec; 33(12):1878-85. PubMed ID: 19898224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
    Zweemer RP; van Diest PJ; Verheijen RH; Ryan A; Gille JJ; Sijmons RH; Jacobs IJ; Menko FH; Kenemans P
    Gynecol Oncol; 2000 Jan; 76(1):45-50. PubMed ID: 10620440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
    Powell CB; Kenley E; Chen LM; Crawford B; McLennan J; Zaloudek C; Komaromy M; Beattie M; Ziegler J
    J Clin Oncol; 2005 Jan; 23(1):127-32. PubMed ID: 15625367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M; Baltoyiannis G; Roukos DH
    Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
    Cass I; Holschneider C; Datta N; Barbuto D; Walts AE; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1327-34. PubMed ID: 16319259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
    Scholz HS; Lax S; Tamussino KF; Benedicic C; Petru E
    Anticancer Res; 2000; 20(6C):4801-2. PubMed ID: 11205221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense?
    Olivier RI; Lubsen-Brandsma LA; van Boven H; van Beurden M
    Gynecol Oncol; 2005 Feb; 96(2):439-43. PubMed ID: 15661233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent metastatic fallopian tube carcinoma in pregnancy.
    Adolph A; Le T; Khan K; Biem S
    Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary transitional cell carcinoma of the fallopian tube.
    Elsokkari I; Napaki S; Greening S; Aghmesheh M
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1767-71. PubMed ID: 21793996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.